A jury sided with Gilead Sciences in a dispute over whether the government could claim a share of profits from drugs seen as crucial to ending the H.I.V. epidemic.
In a largely closeted era, he was a founder of a magazine devoted to gay and lesbian writing and an imprint devoted to L.G.B.T. fiction and nonfiction.